The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway

• Published in: Digestive diseases and sciences 2017-12, Vol.62 (12), p.3426-3437
• Main Authors: Li, Yanhua, Gu, Junjiao, Lu, Hong
• Format: Article
• Language: English
• Subjects: Analysis; Biochemistry; Cancer; Cell growth; Cell Line, Tumor; Development and progression; Gastric cancer; Gastroenterology; Gene Expression Regulation, Neoplastic; Hepatology; Humans; Kinases; Medicine; Medicine & Public Health; MicroRNAs - metabolism; Oncology; Original Article; Phosphatases; Protein kinases; Proteins; Proto-Oncogene Proteins c-akt - metabolism; PTEN Phosphohydrolase - metabolism; RNA; RNA, Long Noncoding - metabolism; Stomach cancer; Stomach Neoplasms - metabolism; TOR Serine-Threonine Kinases - metabolism; Transplant Surgery
• ISSN: 0163-2116; 1573-2568
• DOI: 10.1007/s10620-017-4831-4

Background Several lines of evidence have indicated that growth arrest-specific transcript 5 (GAS5) functions as a tumor suppressor and is aberrantly expressed in multiple cancers. GAS5 was found to be downregulated in gastric cancer (GC) tissues, and ectopic expression of GAS5 inhibited GC cell proliferation. Aims The present study aimed to explore the underlying mechanisms of GAS5 involved in GC cell proliferation. Methods GAS5 and miR-222 expressions in GC cell lines were estimated by quantitative real-time polymerase chain reaction. The effects of GAS5 and miR-222 on GC cell proliferation were assessed by MTT assay and 5-bromo-2-deoxyuridine (BrdU) incorporation assays. The interaction between GAS5 and miR-222 was confirmed by luciferase reporter assay and RNA immunoprecipitation assay. The protein levels of the phosphatase and tensin homolog (PTEN), phosphorylated protein kinase B (Akt) (p-Akt), Akt, phosphorylated mammalian target of rapamycin (mTOR) (p-mTOR), and mTOR were determined by western blot. Results GAS5 was downregulated and miR-222 was upregulated in GC cells. GAS5 directly targeted and suppressed miR-222 expression. GAS5 overexpression and miR-222 inhibition suppressed cell proliferation, increased PTEN protein level and decreased p-Akt and p-mTOR protein levels in GC cells while GAS5 knockdown and miR-222 overexpression exhibited the opposite effects. Moreover, mechanistic analyses revealed that GAS5 regulated GC cell proliferation through the PTEN/Akt/mTOR pathway by negatively regulating miR-222. Conclusions GAS5/miR-222 axis regulated proliferation of GC cells through the PTEN/Akt/mTOR pathway, which facilitated the development of lncRNA-directed therapy against this deadly disease.